Internet-Based Lifestyle Intervention for Prostate Cancer Survivors
(iLIVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an online program called iLIVE, which combines weight loss and resistance training to assist men with prostate cancer who have undergone androgen deprivation therapy (ADT). ADT often leads to weight gain and frailty, potentially lowering quality of life and increasing fall risk. The study aims to determine if iLIVE can address these issues. Men who have had prostate cancer, received ADT for at least six months, are overweight, and show signs of frailty, but are not currently on a structured diet or exercise program, may be suitable for this trial. Participants will either use the iLIVE program or receive usual care, both supported by fitness trackers. As an unphased trial, this study provides a unique opportunity to contribute to research that may improve quality of life for men with prostate cancer.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this internet-based lifestyle intervention is safe for prostate cancer survivors?
Research shows that specific safety information for the iLIVE program, an online lifestyle intervention, is not available. However, similar digital health and web-based lifestyle programs have been well-received, and participants usually find them safe.
These studies often report high retention rates, indicating that participants tend to stay involved. For instance, one study showed that 85.4% of participants remained engaged at three weeks, increasing to 91% at 12 weeks. This suggests that people find the program easy to follow and safe.
In summary, while direct safety data for the iLIVE program is lacking, similar programs have proven safe for participants in past studies.12345Why are researchers excited about this trial?
Researchers are excited about the Internet-Based Lifestyle Intervention for prostate cancer survivors because it's a unique approach that combines digital tools and social support for health improvement. Unlike traditional care, which often focuses on in-person sessions and general health advice, this intervention offers personalized, interactive online weight loss programs and group-based resistance training. It leverages technology such as Fitbits and smart scales to provide real-time feedback and motivation, potentially enhancing engagement and adherence to lifestyle changes. This could lead to better long-term health outcomes for prostate cancer survivors by seamlessly integrating modern technology with healthy lifestyle practices.
What evidence suggests that iLIVE is effective for improving obesity and frailty in prostate cancer survivors?
Research shows that the iLIVE program, available to participants in this trial, combines online weight loss advice with group exercise and may help improve obesity and frailty in men with prostate cancer who have undergone hormone therapy. This therapy often leads to weight gain, weakness, and obesity, which can lower quality of life and increase fall risk. Studies suggest that lifestyle programs like iLIVE can promote healthier weight and strength. Early results from similar programs indicate improvements in physical health and potential reductions in frailty. Therefore, iLIVE offers a promising approach to enhancing the health of prostate cancer survivors facing these challenges.12678
Who Is on the Research Team?
Kerri Winters-Stone
Principal Investigator
OHSU Knight Cancer Institute
Are You a Good Fit for This Trial?
This trial is for English-speaking men over 18 with prostate cancer who've had at least 6 months of ADT in the past decade, are obese but not morbidly so (BMI >30 to <50), show signs of frailty, and have internet access. They shouldn't be on a diet or exercise plan, have other active cancers except non-melanoma skin cancer, or any condition that affects weight/body composition like Cushing's syndrome.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive online access to an interactive weight loss website and participate in online group-based resistance training sessions (iLIVE). They also use a Fitbit fitness tracker and Aria smart scale.
Follow-up
Participants are monitored for changes in obesity, frailty, and other health outcomes after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- iLIVE
iLIVE is already approved in United States for the following indications:
- Obesity and frailty in prostate cancer survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
OHSU Knight Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Oregon Health and Science University
Collaborator
University of Alabama at Birmingham
Collaborator